Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels'
(id=12607604 ; fe=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=385 creation date=2019-05-03 touchdate=2024-09-15 20:15:39.000)
≈ 18 relations sortantes

  1. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 43 / 1 -> en:use of agents affecting estrogen receptors and estrogen levels
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=en:use of agents affecting estrogen receptors and estrogen levels | rel=r_associated | relid=0 | w=43
  2. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 41 / 0.953 -> en:prophylactic use of zoladex
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=en:prophylactic use of zoladex | rel=r_associated | relid=0 | w=41
  3. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 37 / 0.86 -> en:prophylactic use of leuprolide acetate
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=en:prophylactic use of leuprolide acetate | rel=r_associated | relid=0 | w=37
  4. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 35 / 0.814 -> en:encounter due to prophylactic use of aromatase inhibitors
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=en:encounter due to prophylactic use of aromatase inhibitors | rel=r_associated | relid=0 | w=35
  5. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 35 / 0.814 -> en:prophylactic use of fulvestrant
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=en:prophylactic use of fulvestrant | rel=r_associated | relid=0 | w=35
  6. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 32 / 0.744 -> en:prophylactic use of gnrh agonist
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=en:prophylactic use of gnrh agonist | rel=r_associated | relid=0 | w=32
  7. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 32 / 0.744 -> en:use of selective estrogen receptor modulators (serms)
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=en:use of selective estrogen receptor modulators (serms) | rel=r_associated | relid=0 | w=32
  8. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 30 / 0.698 -> en:prophylactic use of leuprorelin
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=en:prophylactic use of leuprorelin | rel=r_associated | relid=0 | w=30
  9. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 29 / 0.674 -> en:encounter due to prophylactic use of megestrol acetate
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=en:encounter due to prophylactic use of megestrol acetate | rel=r_associated | relid=0 | w=29
  10. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 28 / 0.651 -> en:prophylactic use of lupron
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=en:prophylactic use of lupron | rel=r_associated | relid=0 | w=28
  11. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 28 / 0.651 -> en:prophylactic use of megace
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=en:prophylactic use of megace | rel=r_associated | relid=0 | w=28
  12. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 27 / 0.628 -> en:prophylactic use of estrogen receptor downregulators
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=en:prophylactic use of estrogen receptor downregulators | rel=r_associated | relid=0 | w=27
  13. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 27 / 0.628 -> en:prophylactic use of faslodex
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=en:prophylactic use of faslodex | rel=r_associated | relid=0 | w=27
  14. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 27 / 0.628 -> en:prophylactic use of gonadotropin-releasing hormone agonist
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=en:prophylactic use of gonadotropin-releasing hormone agonist | rel=r_associated | relid=0 | w=27
  15. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 26 / 0.605 -> en:prophylactic use of goserelin acetate
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=en:prophylactic use of goserelin acetate | rel=r_associated | relid=0 | w=26
  16. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 25 / 0.581 -> en:encounter
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=en:encounter | rel=r_associated | relid=0 | w=25
  17. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 25 / 0.581 -> récepteur
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=récepteur | rel=r_associated | relid=0 | w=25
  18. en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels -- r_associated #0: 1 / 0.023 -> en:finding
    n1=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | n2=en:finding | rel=r_associated | relid=0 | w=1
≈ 15 relations entrantes

  1. en:use of agents affecting estrogen receptors and estrogen levels --- r_associated #0: 36 --> en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels
    n1=en:use of agents affecting estrogen receptors and estrogen levels | n2=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | rel=r_associated | relid=0 | w=36
  2. en:encounter due to prophylactic use of aromatase inhibitors --- r_associated #0: 35 --> en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels
    n1=en:encounter due to prophylactic use of aromatase inhibitors | n2=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | rel=r_associated | relid=0 | w=35
  3. en:encounter due to prophylactic use of megestrol acetate --- r_associated #0: 20 --> en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels
    n1=en:encounter due to prophylactic use of megestrol acetate | n2=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | rel=r_associated | relid=0 | w=20
  4. en:prophylactic use of estrogen receptor downregulators --- r_associated #0: 20 --> en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels
    n1=en:prophylactic use of estrogen receptor downregulators | n2=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | rel=r_associated | relid=0 | w=20
  5. en:prophylactic use of faslodex --- r_associated #0: 20 --> en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels
    n1=en:prophylactic use of faslodex | n2=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | rel=r_associated | relid=0 | w=20
  6. en:prophylactic use of fulvestrant --- r_associated #0: 20 --> en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels
    n1=en:prophylactic use of fulvestrant | n2=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | rel=r_associated | relid=0 | w=20
  7. en:prophylactic use of gnrh agonist --- r_associated #0: 20 --> en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels
    n1=en:prophylactic use of gnrh agonist | n2=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | rel=r_associated | relid=0 | w=20
  8. en:prophylactic use of gonadotropin-releasing hormone agonist --- r_associated #0: 20 --> en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels
    n1=en:prophylactic use of gonadotropin-releasing hormone agonist | n2=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | rel=r_associated | relid=0 | w=20
  9. en:prophylactic use of goserelin acetate --- r_associated #0: 20 --> en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels
    n1=en:prophylactic use of goserelin acetate | n2=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | rel=r_associated | relid=0 | w=20
  10. en:prophylactic use of leuprolide acetate --- r_associated #0: 20 --> en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels
    n1=en:prophylactic use of leuprolide acetate | n2=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | rel=r_associated | relid=0 | w=20
  11. en:prophylactic use of leuprorelin --- r_associated #0: 20 --> en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels
    n1=en:prophylactic use of leuprorelin | n2=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | rel=r_associated | relid=0 | w=20
  12. en:prophylactic use of lupron --- r_associated #0: 20 --> en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels
    n1=en:prophylactic use of lupron | n2=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | rel=r_associated | relid=0 | w=20
  13. en:prophylactic use of megace --- r_associated #0: 20 --> en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels
    n1=en:prophylactic use of megace | n2=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | rel=r_associated | relid=0 | w=20
  14. en:prophylactic use of zoladex --- r_associated #0: 20 --> en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels
    n1=en:prophylactic use of zoladex | n2=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | rel=r_associated | relid=0 | w=20
  15. en:use of selective estrogen receptor modulators (serms) --- r_associated #0: 20 --> en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels
    n1=en:use of selective estrogen receptor modulators (serms) | n2=en:encounter due to prophylactic use of other agents affecting estrogen receptors and estrogen levels | rel=r_associated | relid=0 | w=20
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr